• Mashup Score: 0

    In older patients with cancer, the balance between harms and benefits of treatment is delicate. There is a higher risk of adverse outcomes of cancer treatment due to comorbidity and geriatric impairments, while clinical benefit is uncertain due to their frequent exclusion in clinical trials [1,2]. Potential benefits of treatment (for example, increased survival) may come at a cost (for example, increased treatment side-effects or loss of function). As a result, treatment decisions are often preference sensitive, which means that the optimal treatment choice depends on a patient’s personal values and priorities [3].

    Tweet Tweets with this article
    • Development and testing of the Outcome Prioritization Tool adjusted to older patients with cancer: A pilot study https://t.co/edybsStsay @WilliamDale_MD @rochgerionc @myCARG #GeriOnc #OlderAdults #OncoAlert #SIOG #YoungSIOG #HealthOutcomePriorities #SharedDecisionMaking https://t.co/4X5NYK9Rxz

  • Mashup Score: 0

    Geriatric assessment and management (GAM) is recommended by professional organizations and recently several randomized controlled trials (RCTs) demonstrated benefits in multiple health outcomes. GAM typically leads to one or more recommendations for the older adult on how to optimize their health. However, little is known about how well recommendations are adhered to. Understanding these issues is vital to designing GAM trials and clinical programs. Therefore, the aim of this study was to examine the number of GAM recommendations made and adherence to and satisfaction with the intervention in a multicentre RCT of GAM for older adults with cancer.

    Tweet Tweets with this article
    • Implementing geriatric assessment and management for older Canadians with cancer: Adherence to and satisfaction with the intervention, results of the 5C study https://t.co/eA71IdIDaM @martine_puts @WilliamDale_MD @rochgerionc @myCARG #GeriOnc #OlderAdults #OncoAlert #SIOG

  • Mashup Score: 0

    As the population is ageing, the number of older patients with multimorbidity including cancer continues to increase. To improve care for these patients, the European Union-funded project “Streamlined Geriatric and Oncological evaluation based on IC Technology” (GERONTE) was initiated to develop a new, patient-centred, holistic care pathway. The aim of this paper is to analyse what challenges are encountered in everyday clinical practice according to patients, their informal caregivers, and healthcare professionals as a starting point for the development of the care pathway.

    Tweet Tweets with this article
    • Challenges of caring for older patients with multimorbidity including cancer https://t.co/6XAavdfIrv @SRostoft @WilliamDale_MD @rochgerionc @myCARG #GeriOnc #OlderAdults #OncoAlert #SIOG #YoungSIOG #QualityofLife #SharedDecisionMaking #SymptomMonitoring #CoordinationofCare

  • Mashup Score: 0

    Patients with hematologic malignancies often require intensive and complex treatment regimens that result in substantial toxicities. They also face significant illness burden and health care utilization making social support critical to optimizing their outcomes [1,2]. Older adults with hematologic malignancies are arguably even more vulnerable, given their higher risk of treatment toxicity due to concurrent cytopenias and associated functional limitations requiring extensive social support.

    Tweet Tweets with this article
    • Marital status, frailty, and survival in older adults with blood cancer https://t.co/ouppfIusTV @jorgeeavila @cdumonti @WilliamDale_MD @rochgerionc @myCARG #GeriOnc #OlderAdults #OncoAlert #SIOG #YoungSIOG #SocialSupports #HematologicMalignancies #MaritalStatus https://t.co/94YrtOvPSL